Used as a key intermediate in the synthesis of tyrosine kinase inhibitors, particularly in pharmaceuticals targeting cancer treatment. It plays a role in the development of compounds that interfere with signal transduction pathways in tumor cells. Its structure supports binding to enzyme active sites, making it valuable in designing drugs for chronic myeloid leukemia and other malignancies. Also employed in research for new anti-angiogenic agents and in the preparation of functionalized succinimide derivatives for biochemical assays.